豐元股份(002805.SZ):擬以定增募集資金7.14億元對豐元鋰能進行增資
格隆匯10月12日丨豐元股份(002805.SZ)公佈,由於本次非公開發行股票募投項目“年產5萬噸鋰電池磷酸鐵鋰正極材料生產基地項目”的實施主體為安徽豐元鋰能科技有限公司(“安徽豐元”),公司擬以非公開發行股份募集資金人民幣7.14億元對全資子公司山東豐元鋰能科技有限公司(“豐元鋰能”)進行增資,並由豐元鋰能對其控股子公司、公司控股孫公司安徽豐元以募集資金4.64億元進行增資。增資完成後,豐元鋰能的註冊資本將增加至12.24億元,公司持有其100%股權;安徽豐元的註冊資本將增加至8.64億元,豐元鋰能持有其82.64%股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.